Integration of metabolomics and network pharmacology technology to explain the effect mechanisms of Danggui Buxue decoction in vascular dementia
Authors:
- 18 January 2024
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 38 (4) , e5822
Abstract
Danggui Buxue decoction (DBD) is a traditional Chinese medicine herbal decoction that has a good therapeutic effect on vascular dementia (VaD). However, its pharmacodynamic substances and underlying mechanisms are ambiguous. The work aimed to decipher the pharmacodynamic substances and molecular mechanisms of DBD against VaD rats based on gas chromatography–mass spectrometry metabonomics, network pharmacology, molecular docking, and experimental verification. The results indicated that DBD significantly improved the learning abilities and cognitive impairment in the VaD rat model. Integration analysis of the metabolomics and network pharmacology approach revealed that DBD might primarily affect arachidonic acid (AA) and inositol phosphate metabolic pathways by regulating the platelet activation signaling pathways. Six core targets (TNF [tumor necrosis factor], IL‐6 [interleukin 6], PTGS2 [prostaglandin‐endoperoxide synthase 2], MAPK1, MAPK3, and TP53) in the platelet activation signaling pathways also had a good affinity to seven main active components (saponins, organic acids, flavonoids, and phthalides) of DBD through the verification of molecular docking. Enzyme‐linked immunosorbent assay results (ELISA) showed that the levels of TNF, IL‐6, PTGS2, thromboxane B2, and caspase‐3 in the platelet activation signaling pathway can be regulated by DBD. Our results indicated that DBD treated VaD mainly by modulating the platelet activation signaling pathway, and AA and inositol phosphate metabolism.Keywords
This publication has 48 references indexed in Scilit:
- Ligustilide alleviates brain damage and improves cognitive function in rats of chronic cerebral hypoperfusionJournal of Ethnopharmacology, 2012
- Moderate Dietary Restriction Reduces p53-Mediated Neurovascular Damage and Microglia Activation After Hypoxic Ischemia in Neonatal BrainStroke, 2012
- Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in miceEuropean Journal of Pharmacology, 2010
- Chlorogenic Acid and Its Metabolitem-Coumaric Acid Evoke Neurite Outgrowth in Hippocampal Neuronal CellsBioscience, Biotechnology, and Biochemistry, 2008
- Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease—But how and why?Prostaglandins, Leukotrienes and Essential Fatty Acids, 2008
- Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3Nature, 2006
- A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer diseaseJournal of Clinical Investigation, 2005
- Expression of Interleukin-1β Converting Enzyme Gene Family and bcl-2 Gene Family in the Rat Brain following Permanent Occlusion of the Middle Cerebral ArteryJournal of Cerebral Blood Flow & Metabolism, 1997
- Characterization of Phospholipase A2 Activity Enriched in the Nerve Growth ConeJournal of Neurochemistry, 1996
- Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brainNeurobiology of Aging, 1996